168 related articles for article (PubMed ID: 15388469)
1. In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.
Shelburne SA; Musher DM; Hulten K; Ceasar H; Lu MY; Bhaila I; Hamill RJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):4016-9. PubMed ID: 15388469
[TBL] [Abstract][Full Text] [Related]
2. Resistance development in community-acquired strains of methicillin-resistant Staphylococcus aureus: an in vitro study.
Munckhof WJ; Kleinschmidt SL; Turnidge JD
Int J Antimicrob Agents; 2004 Dec; 24(6):605-8. PubMed ID: 15555885
[TBL] [Abstract][Full Text] [Related]
3. Methicillin resistance among Trinidadian isolates of community and hospital strains of Staphylococcus aureus and their patterns of resistance to non-beta-lactam antibiotics.
Orrett FA
Jpn J Infect Dis; 1999 Dec; 52(6):238-41. PubMed ID: 10738361
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
6. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
Thamlikitkul V
J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of community-acquired Methicillin-resistant Staphylococcus aureus infection in children].
Hu YH; Zhen JH; Zhao DH
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):298-300. PubMed ID: 16923361
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
Hamel A; Caillon J; Jacqueline C; Batard E; Potel G
Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
[TBL] [Abstract][Full Text] [Related]
9. In vitro exposure of community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains to vancomycin: does vancomycin resistance occur?
Kleinschmidt SL; Munckhof WJ; Nimmo GR
Int J Antimicrob Agents; 2006 Feb; 27(2):168-70. PubMed ID: 16420976
[TBL] [Abstract][Full Text] [Related]
10. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus.
Maggiolo F; Capra R; Bottura P; Pravettoni G; Migliorino M; Suter F
J Chemother; 2000 Jun; 12(3):195-8. PubMed ID: 10877512
[TBL] [Abstract][Full Text] [Related]
12. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
13. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
[TBL] [Abstract][Full Text] [Related]
14. Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains.
Tacconelli E; Venkataraman L; De Girolami PC; DAgata EM
J Antimicrob Chemother; 2004 Mar; 53(3):474-9. PubMed ID: 14762054
[TBL] [Abstract][Full Text] [Related]
15. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Arnold FW; Wojda B
J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
[TBL] [Abstract][Full Text] [Related]
16. Intermediate vancomycin susceptibility in a community-associated MRSA clone.
Graber CJ; Wong MK; Carleton HA; Perdreau-Remington F; Haller BL; Chambers HF
Emerg Infect Dis; 2007 Mar; 13(3):491-3. PubMed ID: 17552110
[TBL] [Abstract][Full Text] [Related]
17. Community associated MRSA: an alert to paediatricians.
Jeyaratnam D; Reid C; Kearns A; Klein J
Arch Dis Child; 2006 Jun; 91(6):511-2. PubMed ID: 16714723
[TBL] [Abstract][Full Text] [Related]
18. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections.
Kourbatova EV; Halvosa JS; King MD; Ray SM; White N; Blumberg HM
Am J Infect Control; 2005 Sep; 33(7):385-91. PubMed ID: 16153484
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureus.
LaPlante KL; Rybak MJ; Amjad M; Kaatz GW
Pharmacotherapy; 2007 Jan; 27(1):3-10. PubMed ID: 17192156
[TBL] [Abstract][Full Text] [Related]
20. MRSA--the tip of the iceberg.
Appelbaum PC
Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():3-10. PubMed ID: 16524422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]